Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ridderstråle

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|March 22, 2005
Signaling mechanism for the insulin-like effects of growth hormone--another example of a classical hormonal negative feedback loopMartin Ridderstråle
Journal of Diabetes Science and Technology|April 4, 2017
Comparison Between Individually and Group-Based Insulin Pump Initiation by Time-Driven Activity-Based CostingMartin Ridderstråle
Lakartidningen|March 8, 2002
[A case report. Rosiglitazone treatment was highly effective yet had to be terminated]Martin Ridderstråle, Leif Groop
Molecular and Cellular Endocrinology|November 13, 2008
Genetic dissection of type 2 diabetesMartin Ridderstråle, Leif Groop
Current Hypertension Reports|March 28, 2008
Type 2 diabetes candidate gene CAPN10: first, but not lastMartin Ridderstråle, Emma Nilsson
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 30, 2026
Six-year Follow-Up of Nonpharmacological and Nonsurgical Obesity TreatmentsMaja J Ekman, Martin Ridderstråle
Current Opinion in Clinical Nutrition and Metabolic Care|June 3, 2005
Calpain 10 and type 2 diabetes: are we getting closer to an explanation?Martin Ridderstråle, Hemang Parikh, Leif Groop
Endocrinology, Diabetes & Metabolism|March 1, 2019
Adult-onset type 1 diabetes: Predictors of glycaemic controlDan Hesse, Louise Boysen, Martin Ridderstråle
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjectsEmma Carlsson, Jenny Fredriksson, Leif Groop, et al.
BMJ Open|March 19, 2018
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in DenmarkNarges Safai, Bendix Carstensen, Henrik Vestergaard, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|March 22, 2005
Signaling mechanism for the insulin-like effects of growth hormone--another example of a classical hormonal negative feedback loopMartin Ridderstråle
Journal of Diabetes Science and Technology|April 4, 2017
Comparison Between Individually and Group-Based Insulin Pump Initiation by Time-Driven Activity-Based CostingMartin Ridderstråle
Lakartidningen|March 8, 2002
[A case report. Rosiglitazone treatment was highly effective yet had to be terminated]Martin Ridderstråle, Leif Groop
Molecular and Cellular Endocrinology|November 13, 2008
Genetic dissection of type 2 diabetesMartin Ridderstråle, Leif Groop
Current Hypertension Reports|March 28, 2008
Type 2 diabetes candidate gene CAPN10: first, but not lastMartin Ridderstråle, Emma Nilsson
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 30, 2026
Six-year Follow-Up of Nonpharmacological and Nonsurgical Obesity TreatmentsMaja J Ekman, Martin Ridderstråle
Current Opinion in Clinical Nutrition and Metabolic Care|June 3, 2005
Calpain 10 and type 2 diabetes: are we getting closer to an explanation?Martin Ridderstråle, Hemang Parikh, Leif Groop
Endocrinology, Diabetes & Metabolism|March 1, 2019
Adult-onset type 1 diabetes: Predictors of glycaemic controlDan Hesse, Louise Boysen, Martin Ridderstråle
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjectsEmma Carlsson, Jenny Fredriksson, Leif Groop, et al.
BMJ Open|March 19, 2018
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in DenmarkNarges Safai, Bendix Carstensen, Henrik Vestergaard, et al.
Pageof 9